Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2014
09/18/2014WO2014144960A2 Fc variants
09/18/2014WO2014144935A2 Anti-cd25 antibodies and their uses
09/18/2014WO2014144865A2 Anti-crth2 antibodies and methods of use
09/18/2014WO2014144722A2 BISPECIFIC-Fc MOLECULES
09/18/2014WO2014144689A1 Pro-drug antibodies against tissue factor pathway inhibitor
09/18/2014WO2014144632A2 Human pac1 antibodies
09/18/2014WO2014144616A2 Anti-alpha v beta 5 antibodies and uses thereof
09/18/2014WO2014144577A1 Anti-tfpi antibody variants with differential binding across ph range for improved pharmacokinetics
09/18/2014WO2014144553A1 Secreted frizzle-related protein 5 (sfrp5) binding proteins and methods of treatment
09/18/2014WO2014144549A1 Factor ix polypeptide formulations
09/18/2014WO2014144511A1 Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
09/18/2014WO2014144495A1 Single cell bar-coding for antibody discovery
09/18/2014WO2014144466A1 Anti-alpha v beta 6 antibodies and uses thereof
09/18/2014WO2014144357A1 Tetravalent bispecific antibodies
09/18/2014WO2014144355A2 Anti-gp73 monoclonal antibodies and methods of obtaining the same
09/18/2014WO2014144299A2 DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST TNFα
09/18/2014WO2014144280A2 DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1β AND / OR IL-17
09/18/2014WO2014144170A1 In-vitro method for monoclonal antibody production using non-human act1 -deficient mice
09/18/2014WO2014144080A2 Human antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9
09/18/2014WO2014144040A1 Lipoprotein-associated phospholipase a2 antibody compositions and methods of use
09/18/2014WO2014143909A1 Anti-prolactin receptor antibody formulations
09/18/2014WO2014143540A1 Methods for treating crohn's disease using an anti-il23 antibody
09/18/2014WO2014143343A1 Hcv core lipid binding domain monoclonal antibodies
09/18/2014WO2014143205A1 Human antibodies that bind human tnf-alpha and methods of preparing the same
09/18/2014WO2014143185A1 Purification of proteins using hydrophobic interaction chromatography
09/18/2014WO2014143184A1 Modulated lysine variant species compositions and methods for producing and using the same
09/18/2014WO2014143087A1 Peptide vaccine for prevention and immunotherapy of dementia of the alzheimer's type
09/18/2014WO2014142882A1 Protein purification using displacement chromatography
09/18/2014WO2014142591A1 Protein in which electrical interaction is introduced within hydrophobic interaction site and preparation method therefor
09/18/2014WO2014142182A1 Monoclonal antibody inhibiting enzymatic activity of endothelial lipase
09/18/2014WO2014142117A1 Anti-staphylococcus antibody, method for manufacturing same, and usage of same
09/18/2014WO2014142084A1 METHOD FOR PRODUCING MONOCLONAL IgA ANTIBODY
09/18/2014WO2014141683A1 Kntc2 peptides and vaccines containing the same
09/18/2014WO2014141652A1 Smyd3 peptides and vaccines containing the same
09/18/2014WO2014141271A1 Use of anti-eotaxin antibodies for treating inflammatory bowel disease
09/18/2014WO2014141192A1 Generation of heavy chain-only antibodies
09/18/2014WO2014141189A1 Transgenic non-human mammal for antibody production
09/18/2014WO2014141150A1 Methods for purifying antibodies
09/18/2014WO2014141145A1 Modified molecules resistant to proteolytic degradation
09/18/2014WO2014141064A1 Notch2 binding molecules for treating respiratory diseases
09/18/2014WO2014140904A2 Antibodies to mica and micb proteins
09/18/2014WO2014140562A1 Immunogenic composition to neisseria
09/18/2014WO2014140376A1 Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases
09/18/2014WO2014140374A2 Monovalent cd27 antibodies
09/18/2014WO2014140368A1 Antibody constructs for influenza m2 and cd3
09/18/2014WO2014140361A1 Formulation of an antibody and use thereof
09/18/2014WO2014140358A1 Single chain binding molecules comprising n-terminal abp
09/18/2014WO2014140330A1 Anti-ddr1 internalizing antibodies and their medical use
09/18/2014WO2014140248A1 Binding molecules for bcma and cd3
09/18/2014WO2014140243A1 Method and pharmaceutical composition for use in the treatment and prediction of myocardial infarction
09/18/2014WO2014140240A1 Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitor
09/18/2014WO2014140180A1 Anti-lag-3 binding proteins
09/18/2014WO2014140176A1 Targeting vaccines for veterinary use
09/18/2014WO2014140113A1 Methods for treating and/or limiting development of diabetes
09/18/2014WO2014139539A1 Inhibitor of dpysl3/crmp4 for treatment of bone loss
09/18/2014WO2014139476A1 Epitope of rsv fusion protein and antibody identifying same
09/18/2014WO2014139425A1 Anti-blys monoclonal antibody and pharmaceutical composition containing antibody
09/18/2014WO2014138887A1 Method for separating cells using immunorosettes and magnetic particles
09/18/2014WO2014138862A1 Human monoclonal antibodies that neutralize bioactivity of granulocyte macrophage colony-stimulating factor and methods and uses thereof
09/18/2014WO2014138819A1 Agents that neutralize il-3 signaling and uses thereof
09/18/2014WO2014138805A1 Anti il-3r alpha agents and uses thereof
09/18/2014WO2013149159A9 Anti-lgr5 antibodies and immunoconjugates
09/18/2014US20140283157 Lipoprotein-associated phospholipase a2 antibody compositions and methods of use
09/18/2014US20140283150 Animal Models and Therapeutic Molecules
09/18/2014US20140275495 Humanized Antibodies That Recognize Alpha-Synuclein
09/18/2014US20140275494 Protein purification using displacement chromatography
09/18/2014US20140275493 Anti-tfpi antibody variants with differential binding across ph range for improved pharmacokinetics
09/18/2014US20140275492 Human monoclonal antibodies and methods for producing the same
09/18/2014US20140275491 Antibodies recognizing human timp1 protein
09/18/2014US20140275490 Novel Anti-Human IL-23 Receptor Antibody
09/18/2014US20140275488 Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof
09/18/2014US20140275487 Binding domains directed against gpcr:g protein complexes and uses derived thereof
09/18/2014US20140275486 Human antibodies that bind human tnf-alpha and methods of preparing the same
09/18/2014US20140275485 Lipoprotein-associated phospholipase a2 antibody compositions and methods of use
09/18/2014US20140275479 Specific binding agents of human angiopoeitin-2
09/18/2014US20140274909 Anti-cd22 chimeric antigen receptors
09/18/2014US20140274882 Methods, compositions, and kits for detection of aspergillosis
09/18/2014US20140274755 Antigen derived from extracellular domain of multi-transmembrane protein and uses thereof
09/18/2014US20140273097 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (fut8) gene expression
09/18/2014US20140273096 Modified coagulation factors with prolonged in vivo half-life
09/18/2014US20140273095 Serum-Free Cell Culture Medium
09/18/2014US20140273094 Methods of enhancing protein quality and quantity by yeast fed-batch fermentation
09/18/2014US20140273093 Methods of producing antibodies in yeast
09/18/2014US20140273092 Manufacturing methods to control c-terminal lysine, galactose and sialic acid content in recombinant proteins
09/18/2014US20140273026 Methods for Detecting Ehrlichia Infection
09/18/2014US20140273023 Gemcitabine immunoassay
09/18/2014US20140273015 BINDING COMPOUNDS TO HUMAN Beta 1-ADRENORECEPTOR (Beta 1-AR) AND THEIR USE IN MEASUREMENT OF AUTO-ANTI- Beta 1-AR ANTIBODIES
09/18/2014US20140273001 Feline bitter taste receptors and methods
09/18/2014US20140272931 Hcv core lipid binding domain monoclonal antibodies
09/18/2014US20140271902 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents
09/18/2014US20140271886 Bioerodible Silicon-Based Compositions for Delivery of Therapeutic Agents
09/18/2014US20140271827 Lipid vesicle compositions and methods of use
09/18/2014US20140271701 Use of mycobacterium avium paratuberculosis peptides to diagnose type 1 diabetes
09/18/2014US20140271698 Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
09/18/2014US20140271686 Anti-(+) -methamphetamine monoclonal antibodies
09/18/2014US20140271685 Internalizing human monoclonal antibodies targeting prostate and other cancer cells
09/18/2014US20140271682 Human homeobox gene ventx and macrophage terminal differentiation and activation, compositions and methods thereof
09/18/2014US20140271681 High Affinity Human Antibodies to Human IL-4 Receptor
09/18/2014US20140271680 Methods and pharmaceutical compositions for treatment of pulmonary hypertension
09/18/2014US20140271679 Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 1494